Bayer Unit Sues Generics Maker Over Acne Treatment

Law360, New York (September 2, 2010, 1:40 PM EDT) -- Bayer HealthCare AG unit Intendis Inc. has accused River's Edge Pharmaceuticals LLC of issuing false statements about a prescription acne medication and inaccurately passing it off as a generic version of the plaintiff's competing treatment.

Intendis lodged a complaint in the U.S. District Court for the District of Maryland on Wednesday, accusing River's Edge and its subsidiary Kylemore Pharmaceuticals LLC of deceptive advertising and unfair trade under the Lanham Act.

According to the suit, River's Edge and Kylemore have disseminated false information to the marketplace regarding...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.